Erratum to: Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002)

Affiliations

• ¹ Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan. [email protected].
• ² Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
• ³ Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
• ⁴ Department of Surgery, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan.
• ⁵ Department of Surgery, Steel Memorial Yawata Hospital, Kitakyushu, Japan.
• ⁶ Department of Surgery, Kurume University Medical Center, Kurume, Japan.
• ⁷ Department of Gastroenterological Surgery, Beppu Medical Center, Beppu, Japan.
• ⁸ Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
• ⁹ Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
• ¹⁰ Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
• ¹¹ Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
• ¹² Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
• ¹³ Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan.